Why We Invested in Iterative Scopes (Computer Vision vs Cancer)

Iterative Scopes is announcing shortly a large seed round and is one of the bets we are making through Tau Ventures, an AI-first seed fund in Silicon Valley. The company was incubated at MIT and impressed us with identifying (1) a strong need, (2) building an execution-focused team, and (3) creating a differentiated product. In our diligence we spoke to various experts including the Head of Gastroenterology at Johns Hopkins and the Chief Innovation Officer of Mount Sinai who is a GI, validating for us the need and the solution. This post is focused specifically on the company but also…...